NCT02516384View on ClinicalTrials.gov

Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Ulcerative Colitis
Interventions
BIOLOGICAL

Fecal Microbiota Transplantation

We will use fecal microbiota transplantation (FMT), with fecal material obtained from OpenBiome or donor directed, to assess safety (as primary outcome) and efficacy (as secondary outcome) in adult (\>18 year old) patients with active ulcerative colitis (UC).

Trial Locations (1)

10021

Weill Cornell Medical College, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT02516384 - Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC) | Biotech Hunter | Biotech Hunter